Hill August 16, 2024
Nathaniel Weixel, Joseph Choi

The first round of negotiated prices of 10 drugs was unveiled by the White House amid much fanfare Thursday, as Democrats celebrated it as a crowning achievement years in the making.

Administration officials touted $6 billion in savings to taxpayers, and about $1.5 billion in savings to seniors’ out-of-pocket spending in 2026.

Here’s what to know:

Negotiations worked — mostly

Drugmakers have said the process was not a legitimate negotiation, but all of them agreed to participate, and none pulled their drugs from the Medicare program.

“The negotiations were comprehensive. They were intense. It took both sides to reach a good deal,” Health and Human Services Secretary Xavier Becerra said of the talks.

Federal officials...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
Podcast: The Scope of Medicare Fraud
A Stronger Medicare Program—Now And Into The Future
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
ACOs Saved Billions in 2023: Can They Sustain This Beyond 2025?
Telehealth under threat: Why Congress must act to save Medicare coverage [PODCAST]

Share This Article